MMP2 and MMP9, the major proteolytic enzymes contributed to ECM degradation, are involved in the process of releasing vascular endothelial growth factor (VEGF), promoting tumor cell migration and invasion [24]. The gene discussed is MMP2; the disease is neoplasm.